Featured CME Activity
How Would You Treat This Patient?
“We are starting to think of small cell as being not just a homogeneous disease that you treat with one platinum doublet anymore, but actually as subtypes with respect to molecular profiling where you could start to think about targeting therapeutic vulnerabilities for small cell patients with subtype A versus subtype B, C, and D.”, Anne Chiangnn
Anne Chiang, MD, PhD, is an Associate Professor of Medicine, Chief Network Officer, and Deputy Chief Medical Officer at the Smilow Cancer Network of Yale School of Medicine. She specializes in thoracic oncology and has an intensive background in translational research in metastasis. Dr. Chiang’s research goals and clinical focus are to create a small cell lung cancer program at Yale, which would include clinical trials and translational studies for both small cell and non–small cell lung cancers. She also finds importance in improving patient-centered cancer services and improving the use of patient-reported outcomes.
“Radiotherapy has a crucial role in small cell lung cancer in many contexts, whether it's definitive, consolidative, prophylactic, or palliative.”, Henry Park.
Henry Park, MD, MPH, is an Associate Professor of Therapeutic Radiology, Vice Chair for Clinical Research and Therapeutic Radiology, and Chief of Thoracic Radiotherapy at the Smilow Cancer Network of Yale School of Medicine. He specializes in radiation therapy for small cell lung cancers and head and neck cancer. Dr. Park is actively involved in clinical trials, having participated in over 120 peer-reviewed research articles. In addition, Dr. Park shows passion for his research by staying involved in and distilling the importance of patient care and medical education.
Earn CME | NCPD | CPE on the go by listening to this accredited activity as a podcast. Click HERE to start listening now!